SRSF2 and myelodysplastic syndrome: Likewise, a splicing abnormality of RUNX1, a recurrently mutated transcription factor in MDS, has been observed in bone marrow cells from two cases with SRSF2 mutations, and aberrant splicing of the epigenetic modifier TET2 has been associated with mutations in U2AF35 [4].